---
figid: PMC3289531__peds.2011-2912fig02
figlink: /pmc/articles/PMC3289531/figure/fig2/
number: F2
caption: 'A, Hepatic BCAA metabolism. BCAAs induce: excess formation of alanine, which
  serves as a substrate for gluconeogenesis, contributing to hyperglycemia; excess
  formation of α-ketoacids, leading to increased levels of C5 and C3 acylcarnitine
  levels and subsequently excess formation of malonyl-CoA, which inhibits β-oxidation;
  hepatic lipid droplet formation and steatosis; activation of mTOR and its downstream
  target S6K, which contributes to serine phosphorylation of IRS-1 and hepatic IR,
  which in turn promotes hyperinsulinemia and influences substrate deposition into
  fat; and export of free fatty acids, which leads to VLDL formation and muscle IR.
  α-KG, α-ketoglutarate; BCKA, branched-chain keto acid; pSer-IRS-1, serine phosphorylated
  IRS-1; S6K, S6 kinase. B, Hepatic ethanol metabolism. Ethanol induces: DNL and dyslipidemia;
  JNK-1 activation, which serine phosphorylates hepatic IRS-1, rendering it inactive,
  and contributing to hepatic IR, which promotes hyperinsulinemia and influences substrate
  deposition into fat; hepatic lipid droplet formation, leading to steatosis; and
  stimulation of the reward pathway, promoting continuous consumption. (Reproduced
  from Lustig.) ACC, acetyl CoA carboxylase; ACL, adenosine triphosphate citrate lyase;
  FAS, fatty acid synthase; MTP, microsomal transfer protein. C, Hepatic fructose
  metabolism. Fructose induces substrate-dependent phosphate depletion, which increases
  uric acid and contributes to hypertension through inhibition of endothelial nitric
  oxide synthase and reduction of NO; DNL and dyslipidemia; hepatic lipid droplet
  formation and steatosis; muscle IR; JNK-1 activation, contributing to hepatic IR,
  which promotes hyperinsulinemia and influences substrate deposition into fat; and
  CNS hyperinsulinemia, which antagonizes central leptin signaling and promotes continued
  energy intake. (Reproduced from Lustig.) ACC, acetyl CoA carboxylase; ACL, adenosine
  triphosphate citrate lyase; ACSS2, acyl-CoA synthetase short-chain family member
  2; AMP, adenosine monophosphate; BP, blood pressure; CNS, central nervous system;
  FAS, fatty acid synthase; Glut5, glucose transporter 5; MTP, microsomal transfer
  protein; NO, nitric oxide; pSer-IRS-1, serine phosphorylated IRS-1.'
pmcid: PMC3289531
papertitle: Toward a Unifying Hypothesis of Metabolic Syndrome.
reftext: Andrew A. Bremer, et al. Pediatrics. 2012 Mar;129(3):557-570.
pmc_ranked_result_index: '140775'
pathway_score: 0.9243774
filename: peds.2011-2912fig02.jpg
figtitle: A, Hepatic BCAA metabolism
year: '2012'
organisms: Homo sapiens
ndex: 06cf4a87-deb0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3289531__peds.2011-2912fig02.html
  '@type': Dataset
  description: 'A, Hepatic BCAA metabolism. BCAAs induce: excess formation of alanine,
    which serves as a substrate for gluconeogenesis, contributing to hyperglycemia;
    excess formation of α-ketoacids, leading to increased levels of C5 and C3 acylcarnitine
    levels and subsequently excess formation of malonyl-CoA, which inhibits β-oxidation;
    hepatic lipid droplet formation and steatosis; activation of mTOR and its downstream
    target S6K, which contributes to serine phosphorylation of IRS-1 and hepatic IR,
    which in turn promotes hyperinsulinemia and influences substrate deposition into
    fat; and export of free fatty acids, which leads to VLDL formation and muscle
    IR. α-KG, α-ketoglutarate; BCKA, branched-chain keto acid; pSer-IRS-1, serine
    phosphorylated IRS-1; S6K, S6 kinase. B, Hepatic ethanol metabolism. Ethanol induces:
    DNL and dyslipidemia; JNK-1 activation, which serine phosphorylates hepatic IRS-1,
    rendering it inactive, and contributing to hepatic IR, which promotes hyperinsulinemia
    and influences substrate deposition into fat; hepatic lipid droplet formation,
    leading to steatosis; and stimulation of the reward pathway, promoting continuous
    consumption. (Reproduced from Lustig.) ACC, acetyl CoA carboxylase; ACL, adenosine
    triphosphate citrate lyase; FAS, fatty acid synthase; MTP, microsomal transfer
    protein. C, Hepatic fructose metabolism. Fructose induces substrate-dependent
    phosphate depletion, which increases uric acid and contributes to hypertension
    through inhibition of endothelial nitric oxide synthase and reduction of NO; DNL
    and dyslipidemia; hepatic lipid droplet formation and steatosis; muscle IR; JNK-1
    activation, contributing to hepatic IR, which promotes hyperinsulinemia and influences
    substrate deposition into fat; and CNS hyperinsulinemia, which antagonizes central
    leptin signaling and promotes continued energy intake. (Reproduced from Lustig.)
    ACC, acetyl CoA carboxylase; ACL, adenosine triphosphate citrate lyase; ACSS2,
    acyl-CoA synthetase short-chain family member 2; AMP, adenosine monophosphate;
    BP, blood pressure; CNS, central nervous system; FAS, fatty acid synthase; Glut5,
    glucose transporter 5; MTP, microsomal transfer protein; NO, nitric oxide; pSer-IRS-1,
    serine phosphorylated IRS-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACACA
  - PPARGC1B
  - ACLY
  - PRKCA
  - CS
  - PRKCI
  - ACACB
  - IRS1
  - MLXIPL
  - PRKCZ
  - PRKCQ
  - ARID4B
  - PRKCE
  - PRKD3
  - C3
  - SLC2A1
  - PRKCD
  - WDTC1
  - PPARGC1A
  - LPL
  - PCSK7
  - MTTP
  - MTOR
  - PRKCB
  - ELP1
  - FAS
  - SREBF1
  - MAPK8
  - PRKCG
  - LGI1
  - ATIC
  - PRKCH
  - TG
  - CS acylcarnitine
  - acyl-CoA C3 acylcarnitine
  - Acetaldehyde
  - Acetate
  - Acyl-CoA
  - acyl-CoA
  - Alanine
  - Ethanol
  - Dihydroxyacetone
  - Fructose
  - Fructose-1,6-bis-P
  - Fructose-1-P
  - Fructose-6-P
  - FructoseATP
  - Glyceraldehyde
  - Malonyl-CoAAcyl
  - Pyruvate
  - Uric Acid INO
  - Xylulose-5-P
genes:
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: PGC-1B
  symbol: PGC1B
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1B
  entrez: '133522'
- word: ACL/ACC
  symbol: ACL
  source: hgnc_alias_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: CS
  symbol: CS
  source: hgnc_symbol
  hgnc_symbol: CS
  entrez: '1431'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: CHREBP
  symbol: CHREBP
  source: hgnc_alias_symbol
  hgnc_symbol: MLXIPL
  entrez: '51085'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: BCAA
  symbol: BCAA
  source: hgnc_alias_symbol
  hgnc_symbol: ARID4B
  entrez: '51742'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: C3
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: Gluts
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: PGC-1
  symbol: PGC1
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: LPL
  symbol: LPL
  source: hgnc_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: LPC
  symbol: LPC
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK7
  entrez: '9159'
- word: MTP,
  symbol: MTP
  source: hgnc_prev_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: MTOR/S6K
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: Dys-
  symbol: DYS
  source: hgnc_prev_symbol
  hgnc_symbol: ELP1
  entrez: '8518'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: SREBP-1c
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: JNK-1,
  symbol: JNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: EPT
  symbol: EPT
  source: hgnc_prev_symbol
  hgnc_symbol: LGI1
  entrez: '9211'
- word: Нерatic
  symbol: ATIC
  source: hgnc_symbol
  hgnc_symbol: ATIC
  entrez: '471'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
chemicals:
- word: CS acylcarnitine
  source: MESH
  identifier: C116917
- word: acyl-CoA C3 acylcarnitine
  source: MESH
  identifier: C116917
- word: Acetaldehyde
  source: MESH
  identifier: D000079
- word: Acetate
  source: MESH
  identifier: D000085
- word: Acyl-CoA
  source: MESH
  identifier: D000214
- word: acyl-CoA
  source: MESH
  identifier: D000214
- word: Alanine
  source: MESH
  identifier: D000409
- word: Ethanol
  source: MESH
  identifier: D000431
- word: Dihydroxyacetone
  source: MESH
  identifier: D004098
- word: Fructose
  source: MESH
  identifier: D005632
- word: Fructose-1,6-bis-P
  source: MESH
  identifier: D005632
- word: Fructose-1-P
  source: MESH
  identifier: D005632
- word: Fructose-6-P
  source: MESH
  identifier: D005632
- word: FructoseATP
  source: MESH
  identifier: D005632
- word: Glyceraldehyde
  source: MESH
  identifier: D005985
- word: Malonyl-CoAAcyl
  source: MESH
  identifier: D008316
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Uric Acid INO
  source: MESH
  identifier: D014527
- word: Xylulose-5-P
  source: MESH
  identifier: D014996
diseases: []
figid_alias: PMC3289531__F2
redirect_from: /figures/PMC3289531__F2
figtype: Figure
---
